A carregar...
Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?
BACKGROUND: The causality of overactive bladder syndrome (OAB) is still not fully understood. Several studies indicate a significant increase of prostaglandin E2 (PGE2) in patients with OAB. However, in order to clarify whether these compounds can help to objectify the clinical diagnosis, further st...
Na minha lista:
| Publicado no: | BMC Urol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4230352/ https://ncbi.nlm.nih.gov/pubmed/25370343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2490-14-85 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|